SAPHMIRATE-T50 Butamirate Citrate 50mg Sustained Release Tablet 1's
SAPHMIR-ZARFGQ
Discreet Packaging
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
FDA-registered Products
FDA-licensed Pharmacies
Sellers of this product
Features
Brand
SAPHMIRATE-T50
Full Details
Dosage Strength
50mg
Drug Ingredients
- Butamirate Citrate
Drug Packaging
Sustained Release Tablet 1's
Generic Name
Butamirate Citrate
Dosage Form
Sustained Release Tablet
Registration Number
DRP-9828
Drug Classification
Over-The-Counter (OTC)
Description
Indications
Symptomatic treatment of acute cough of any origin. Used for cough sedation before and after operation.
Dosage
Adult: As 50 mg tab: 2 or 3 tabs daily at intervals of 8 or 12 hours. As 7.5 mg/5 mL syr: 22.5 mg (15 mL) up to 4 times daily. Max: 90 mg (60 mL) daily.
Administration
Administer with or without food.
Contraindications
Hypersensitivity to any component of the formulation. Refer to manufacturer labeling for further detail.
Pregnancy Interactions
Contraindicated: 1st trimester of pregnancy
Special Precautions
Hepatic and renal impairment. Pregnancy and lactation.
Storage
Store below 30°C.
MedsGo Class
Cough & Cold Preparations
Please sign in so that we can notify you about a reply